EIM
AMED

Essex Investment Management’s Amedisys AMED Stock Holding History

Essex Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,506
Closed -$1.46M – 420
2021
Q1 		$1.46M Sell
5,506
-572
-9% -$161K 0.18% 187
2020
Q4 		$1.78M Sell
6,078
-1,850
-23% -$474K 0.22% 151
2020
Q3 		$1.87M Hold
7,928
– – 0.27% 118
2020
Q2 		$1.57M Buy
+7,928
New +$1.48M 0.26% 122

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Essex Investment Management's AMED Position: Q2 2021 in Review

Essex Investment Management sold out of Amedisys (AMED) in Q2 2021, closing a stake of 5,506 shares — an estimated $1.46M sold.

Essex Investment Management first reported a position in AMED in Q2 2020 and held it in 4 quarters. The position peaked at $1.87M in Q3 2020. 376 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Essex Investment Management reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Essex Investment Management sold 5,506 Amedisys shares in Q2 2021, an estimated $1.46M.
  • Essex Investment Management first reported a position in Amedisys in Q2 2020 and held it in 4 quarters.
  • Essex Investment Management's Amedisys position peaked at $1.87M in Q3 2020.
  • 376 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Essex Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.